HomeCorticosteroidsCorticosteroids + Inebilizumab

Does Corticosteroids Interact with Inebilizumab?

Corticosteroids and Inebilizumab have a moderate drug interaction according to U.S. FDA drug labeling data. Concomitant usage may increase the risk of infection due to additive immune system effects. The mechanism involves additive immunosuppressive effects. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Inebilizumab Class
CD19-directed Cytolytic Antibody
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Corticosteroids and Inebilizumab occurs because additive immunosuppressive effects. Clinically, this means concomitant usage may increase the risk of infection due to additive immune system effects. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Corticosteroids and your doctor is considering prescribing Inebilizumab (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Corticosteroids(Neo-Polycin HC)+💊 Inebilizumab(Uplizna)

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Drug B class
CD19-directed Cytolytic Antibody
Source
NLP:inebilizumab

What this means in plain English

Concomitant usage may increase the risk of infection due to additive immune system effects.

About Corticosteroids and Inebilizumab

Inebilizumab is a CD19-directed Cytolytic Antibody. You may recognize them by the brand names Neo-Polycin HC and Uplizna. Inebilizumab is given by intravenous (IV) infusion.

What the FDA label says

"Additive immunosuppressive effects"

📖 Source: NLP:inebilizumab

Recent research & FDA safety updates

Live

Auto-aggregated from PubMed E-utilities and FDA safety data.

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Corticosteroids and Inebilizumab against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.